Barry E. Storer

40.7k total citations · 7 hit papers
429 papers, 28.2k citations indexed

About

Barry E. Storer is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Barry E. Storer has authored 429 papers receiving a total of 28.2k indexed citations (citations by other indexed papers that have themselves been cited), including 285 papers in Hematology, 119 papers in Oncology and 105 papers in Immunology. Recurrent topics in Barry E. Storer's work include Hematopoietic Stem Cell Transplantation (249 papers), Acute Myeloid Leukemia Research (85 papers) and Acute Lymphoblastic Leukemia research (73 papers). Barry E. Storer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (249 papers), Acute Myeloid Leukemia Research (85 papers) and Acute Lymphoblastic Leukemia research (73 papers). Barry E. Storer collaborates with scholars based in United States, South Africa and Germany. Barry E. Storer's co-authors include Rainer Storb, Brenda M. Sandmaier, David G. Maloney, Paul J. Martin, Michael B. Maris, Mohamed L. Sorror, Ted Gooley, John Crowley, Wendy M. Leisenring and Frederick R. Appelbaum and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Barry E. Storer

423 papers receiving 27.6k citations

Hit Papers

Estimation of failure probabilities in the presence of co... 1989 2026 2001 2013 1999 2005 1992 2001 1989 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
    1999 2.1k citations Ted Gooley, Wendy M. Leisenring et al. Statistics in Medicine profile →
  2. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    2005 2.0k citations Mohamed L. Sorror, Michael B. Maris et al. Blood profile →
  3. Screening Sigmoidoscopy and Colorectal Cancer Mortality
    1992 707 citations Barry E. Storer et al. profile →
  4. Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers
    2001 700 citations William Bensinger, Paul J. Martin et al. profile →
  5. Design and Analysis of Phase I Clinical Trials
    1989 604 citations Barry E. Storer profile →
  6. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
    2011 453 citations Mary E.D. Flowers, Yoshihiro Inamoto et al. Blood profile →
  7. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
    2010 383 citations Barry E. Storer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry E. Storer United States 85 16.5k 8.4k 6.4k 5.3k 3.5k 429 28.2k
Mary M. Horowitz United States 91 20.8k 1.3× 7.8k 0.9× 8.1k 1.3× 6.1k 1.1× 4.9k 1.4× 368 28.5k
Hillard M. Lazarus United States 76 13.4k 0.8× 7.0k 0.8× 3.9k 0.6× 5.6k 1.0× 5.9k 1.7× 545 25.8k
Robert J. Soiffer United States 89 15.0k 0.9× 7.1k 0.8× 10.6k 1.7× 3.3k 0.6× 3.7k 1.1× 506 25.4k
Sergio Giralt United States 86 21.4k 1.3× 10.0k 1.2× 7.0k 1.1× 4.9k 0.9× 5.0k 1.4× 856 30.2k
Mohamad Mohty France 82 18.6k 1.1× 7.6k 0.9× 6.4k 1.0× 5.9k 1.1× 3.4k 1.0× 928 26.0k
Aloïs Gratwohl Switzerland 80 17.1k 1.0× 4.7k 0.6× 5.7k 0.9× 4.4k 0.8× 4.8k 1.4× 515 23.8k
Stephanie J. Lee United States 85 15.8k 1.0× 5.7k 0.7× 5.9k 0.9× 6.8k 1.3× 4.5k 1.3× 629 26.1k
Dietger Niederwieser Germany 73 18.3k 1.1× 5.4k 0.6× 6.1k 1.0× 4.5k 0.8× 7.5k 2.2× 535 26.8k
Ted Gooley United States 73 10.3k 0.6× 4.9k 0.6× 4.7k 0.7× 3.0k 0.6× 2.2k 0.6× 322 18.3k
Daniel J. Weisdorf United States 96 24.2k 1.5× 11.4k 1.4× 13.3k 2.1× 6.3k 1.2× 5.1k 1.5× 732 38.4k

Countries citing papers authored by Barry E. Storer

Since Specialization
Citations

This map shows the geographic impact of Barry E. Storer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry E. Storer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry E. Storer more than expected).

Fields of papers citing papers by Barry E. Storer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry E. Storer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry E. Storer. The network helps show where Barry E. Storer may publish in the future.

Co-authorship network of co-authors of Barry E. Storer

This figure shows the co-authorship network connecting the top 25 collaborators of Barry E. Storer. A scholar is included among the top collaborators of Barry E. Storer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry E. Storer. Barry E. Storer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2022). Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation. Blood Advances. 6(8). 2608–2617. 5 indexed citations
2.
Casto, Amanda M., Sachiko Seo, David Levine, et al.. (2021). Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Blood. 138(17). 1628–1636. 5 indexed citations
3.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2020). Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation. Blood Advances. 4(14). 3224–3233. 17 indexed citations
4.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2016). Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 129(6). 791–798. 76 indexed citations
5.
Inamoto, Yoshihiro, Paul J. Martin, Mary E.D. Flowers, et al.. (2016). Genetic risk factors for sclerotic graft-versus-host disease. Blood. 128(11). 1516–1524. 9 indexed citations
6.
Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations
7.
Davison, Jerry, Xiaoyu Qu, Colm Morrissey, et al.. (2016). Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer. Epigenetics. 11(4). 247–258. 36 indexed citations
8.
Mielcarek, Marco, T Furlong, Barry E. Storer, et al.. (2015). Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial. Haematologica. 100(6). 842–848. 60 indexed citations
9.
Flowers, Mary E.D., Yoshihiro Inamoto, Paul A. Carpenter, et al.. (2011). Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 117(11). 3214–3219. 453 indexed citations breakdown →
10.
Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations
11.
Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning. Journal of Clinical Oncology. 26(30). 4912–4920. 182 indexed citations
12.
Flowers, Mary E.D., Barry E. Storer, Paul A. Carpenter, et al.. (2008). Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 14(12). 1380–1384. 44 indexed citations
13.
Maris, Michael B., Brenda M. Sandmaier, Barry E. Storer, et al.. (2006). Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing. Biology of Blood and Marrow Transplantation. 12(4). 454–465. 75 indexed citations
14.
Sorror, Mohamed L., Michael B. Maris, Rainer Storb, et al.. (2005). Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 106(8). 2912–2919. 1977 indexed citations breakdown →
15.
Hegenbart, Ute, Dietger Niederwieser, Brenda M. Sandmaier, et al.. (2005). Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors. Journal of Clinical Oncology. 24(3). 444–453. 181 indexed citations
16.
Gooley, Ted, Wendy M. Leisenring, John Crowley, & Barry E. Storer. (1999). Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine. 18(6). 695–706. 2124 indexed citations breakdown →
17.
18.
Witt, Patricia L., Daniel A. Goldstein, Barry E. Storer, et al.. (1992). Absence of Biological Effects of Orally Administered Interferon-β ser. Journal of Interferon Research. 12(6). 411–413. 36 indexed citations
19.
Schiller, Joan H., Barry E. Storer, Gerard Bittner, & Michel A. Horisberger. (1990). Characterization of the Synergistic Antiproliferative Effects of Interferon-γ and Tumor Necrosis Factor on Human Colon Carcinoma Cell Lines. Journal of Interferon Research. 10(2). 129–139. 8 indexed citations
20.
Schiller, Joan H., et al.. (1988). Phase II Trial of a Combination of Interferon-β ser and Interferon-γ in Patients with Advanced Malignant Melanoma. Journal of Interferon Research. 8(5). 581–589. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary M. Horowitz Breakdown of academic impact, for papers by Hillard M. Lazarus Breakdown of academic impact, for papers by Robert J. Soiffer Breakdown of academic impact, for papers by Sergio Giralt Breakdown of academic impact, for papers by Mohamad Mohty Breakdown of academic impact, for papers by Aloïs Gratwohl Breakdown of academic impact, for papers by Stephanie J. Lee Breakdown of academic impact, for papers by Dietger Niederwieser Breakdown of academic impact, for papers by Ted Gooley Breakdown of academic impact, for papers by Daniel J. Weisdorf
Rankless by CCL
2026